Literature DB >> 3575728

Embolization in cataclysmal hemorrhage caused by squamous cell carcinomas of the head and neck.

H I Wilner, A Lazo, J J Metes, K A Beil, P Nowack, J Jacobs.   

Abstract

Cataclysmal hemorrhage occurred in eight patients with known aggressive squamous cell tumors of the head and neck. Angiography showed neovascularity, narrowing, beading of affected arteries, and pseudoaneurysms. Postembolization residual stump formation was seen in a few patients. A total of 11 embolization procedures were performed in these eight patients. Embolization materials included polyvinyl alcohol, isobutyl-2-cyanoacrylate, and detachable balloons. Survival times ranged from 5 to 274 days, with no deaths as a direct result of hemorrhage. Only one severe complication following embolization was noted.

Entities:  

Mesh:

Year:  1987        PMID: 3575728     DOI: 10.1148/radiology.163.3.3575728

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

Review 1.  Interventional neuroradiology of the head and neck.

Authors:  D Gandhi; J J Gemmete; S A Ansari; S K Gujar; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-10       Impact factor: 3.825

2.  Endovascular embolization to control life-threatening epistaxis due to a post radiotherapy pseudoaneurysm of the maxillary artery.

Authors:  P Y Marcy; N Magné; C Bailet; G Poissonnet; R J Bensadoun; F Demard
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

3.  Transcutaneous arterial embolization to control massive tumor bleeding in head and neck cancer: 63 patients' experiences from a single medical center.

Authors:  Wen-Chi Chou; Chang-Hsien Lu; Gigin Lin; Yu-Shin Hong; Ping-Tsung Chen; Hung-Chih Hsu; Jen-Shi Chen; Kun-Yun Yeh; Hung-Ming Wang; Chuang-Chi Liaw
Journal:  Support Care Cancer       Date:  2007-03-14       Impact factor: 3.603

4.  CT angiography before embolization for hemorrhage in head and neck cancer.

Authors:  Daniel N Goodman; Brian L Hoh; James D Rabinov; Johnny C Pryor
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.